CARM
Price:
$0.0061
Market Cap:
$255.25K
Carisma Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to pioneering chimeric antigen receptor (CAR) macrophage therapies specifically designed to target solid cancerous growths. Its therapeutic approaches are instrumental in modulating both the inherent and acquired functions of the immune system. The company's sophisticated platform draws upon breakthroughs in macrophage science, CAR design, and cell-based treatments to address various human ailments. Notably, Carisma Therapeutics maintains a key strategic alliance with Moderna Inc. Incorporated in 2016 and headquartered in Philadelphia, Pennsylvania, the organization was initially established as CARMA Therapeutics Inc.,...[Read more]
Industry
Biotechnology
IPO Date
2014-02-06
Stock Exchange
OTC
Ticker
CARM
According to Carisma Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.03. This represents a change of -112.63% compared to the average of -0.24 of the last 4 quarters.
The mean historical PE Ratio of Carisma Therapeutics, Inc. over the last ten years is -44.19. The current 0.03 PE Ratio has changed -106.79% with respect to the historical average. Over the past ten years (40 quarters), CARM's PE Ratio was at its highest in in the December 2021 quarter at 4.54. The PE Ratio was at its lowest in in the June 2021 quarter at -22.27.
Average
-44.19
Median
-1.42
Minimum
-442.23
Maximum
21.29
Discovering the peaks and valleys of Carisma Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.76%
Maximum Annual PE Ratio = 21.29
Minimum Annual Increase = -1345.87%
Minimum Annual PE Ratio = -442.23
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.29 | -74.61% |
| 2023 | -1.13 | -85.89% |
| 2022 | -8.02 | -98.19% |
| 2021 | -442.23 | 7.76% |
| 2020 | -5.63 | 540.03% |
| 2019 | -0.88 | -66.22% |
| 2018 | -2.60 | 257.08% |
| 2017 | -0.73 | -103.42% |
| 2016 | 21.29 | -1345.87% |
| 2015 | -1.71 | -66.08% |
The current PE Ratio of Carisma Therapeutics, Inc. (CARM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.14
5-year avg
-91.46
10-year avg
-44.19
Carisma Therapeutics, Inc.’s PE Ratio is greater than Jasper Therapeutics, Inc. (-0.16), greater than Onconetix, Inc. (-0.07), greater than Enveric Biosciences, Inc. (-0.28), greater than SciSparc Ltd. (-0.03), greater than Silexion Therapeutics Ltd. (-0.08), greater than Salarius Pharmaceuticals, Inc. (-0.25), greater than Revelation Biosciences, Inc. (-0.32), greater than CDT Equity Inc. (0.00), greater than Indaptus Therapeutics, Inc. (-0.41), greater than Aspire Biopharma Holdings, Inc. (-0.63),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.16 | $7.44M | |
| -0.07 | $340.71K | |
| -0.28 | $913.43K | |
| -0.03 | $494.52K | |
| -0.08 | $1.31M | |
| -0.25 | $4.92M | |
| -0.32 | $3.89M | |
| 0.00 | $3.38M | |
| -0.41 | $6.27M | |
| -0.63 | $572.25K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carisma Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Carisma Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Carisma Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Carisma Therapeutics, Inc. (CARM)?
What is the highest PE Ratio for Carisma Therapeutics, Inc. (CARM)?
What is the 3-year average PE Ratio for Carisma Therapeutics, Inc. (CARM)?
What is the 5-year average PE Ratio for Carisma Therapeutics, Inc. (CARM)?
How does the current PE Ratio for Carisma Therapeutics, Inc. (CARM) compare to its historical average?